PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAmta Laboratories
Amta Laboratories
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
DiltiazemDiltiazem2022-08-08
Atrial fibrillation
,
Hypertension
,
Myocardial infarction
,
Atrial flutter
,
Supraventricular tachycardia
,
Variant angina pectoris
,
Heart failure
,
Diabetic nephropathies
,
Left ventricular dysfunction
,
Rheumatoid arthritis
,
Edema
,
Malignant hypertension
,
Bartter syndrome
DivalproexDivalproex2021-03-15
—
MetforminMetformin2021-08-032023-2035
Type 2 diabetes mellitus
MycophenolicMycophenolic2021-02-10
Psoriasis,
Graft vs host disease
PropranololPropranolol2020-01-062028
Heart failure,
Hypertension,
Myocardial infarction,
Pheochromocytoma,
Angina pectoris,
Ventricular tachycardia,
Hemangioma,
Essential tremor,
Esophageal and gastric varices,
Ventricular fibrillation,
Supraventricular tachycardia,
Panic disorder,
Nephrotic syndrome,
Edema
TolterodineTolterodine2021-02-02
Urinary incontinence,
Urinary bladder diseases
TrospiumTrospium2021-04-30
Overactive urinary bladder,
Urge urinary incontinence
NisoldipineNisoldipine2023-04-10
Hypertension,
Variant angina pectoris
MesalamineMesalamine2023-06-062027-2030
Ulcerative colitis,
Proctitis,
Sigmoid diseases
TopiramateTopiramate2024-12-032027-2040
Pain,
Epilepsy,
Lennox gastaut syndrome,
Infantile spasms,
Partial epilepsies,
Tonic-clonic epilepsy,
Bipolar disorder,
Obesity
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use